AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
LAMOTRIGINE
164 registrations across 12 African markets— 135 active
Markets with LAMOTRIGINE
🇿🇦South Africa
83 registrations
67 active
🇲🇦Morocco
22 registrations
22 active
🇺🇬Uganda
12 registrations
12 active
🇿🇼Zimbabwe
9 registrations
9 active
🇹🇳Tunisia
9 registrations
0 active
🇹🇿Tanzania
8 registrations
8 active
🇲🇬Madagascar
6 registrations
6 active
🇰🇪Kenya
5 registrations
5 active
🇸🇳Senegal
5 registrations
5 active
🇲🇼Malawi
3 registrations
0 active
🇿🇲Zambia
1 registration
1 active
🇳🇬Nigeria
1 registration
0 active
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LAMIGARD TABLET; ORAL | 🇿🇼Zimbabwe | ORANGE HEALTH P/L | active | Jun 2031 |
| LAMITOR-25 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT PHARMACEUTICALS | active | Sept 2030 |
| EPSYLAM DT 100 Dispersible Tablet | 🇰🇪Kenya | AUROBINDO PHARMA LIMITED | active | Jul 2030 |
| Lamitor 100 tablets Film Coated Tablets | 🇿🇲Zambia | Torrent Pharmaceutical Limited | active | Jul 2030 |
| LAMITOR-50 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT PHARMACEUTICALS | active | Jun 2030 |
| EPSYLAM DT 25 Tablet | 🇰🇪Kenya | AUROBINDO PHARMA LIMITED | active | May 2030 |
| Orilam ODT 50 Tablet | 🇰🇪Kenya | Micro Labs Limited | active | May 2030 |
| Orilam ODT - 25 Tablet | 🇰🇪Kenya | Micro Labs Limited | active | May 2030 |
| EPSYLAM DT 50 Tablet | 🇰🇪Kenya | AUROBINDO PHARMA LIMITED | active | May 2030 |
| LAMITOR DT 50 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT EXPORTS LTD | active | May 2030 |
| LAMITOR DT 100 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT EXPORTS LTD | active | May 2030 |
| LAMITOR DT 25 TABLET; ORAL | 🇿🇼Zimbabwe | TORRENT EXPORTS LTD | active | May 2030 |
| LAMODEP 50 TABLET; ORAL | 🇿🇼Zimbabwe | UNICHEM LABORATORIES LIMITED | active | Dec 2027 |
| LAMODEP 25 TABLET; ORAL | 🇿🇼Zimbabwe | UNICHEM LABORATORIES LIMITED | active | Dec 2027 |
| LAMODEP 100 TABLET; ORAL | 🇿🇼Zimbabwe | UNICHEM LABORATORIES LIMITED | active | Dec 2027 |
| RIGADEL 100 | 🇿🇦South Africa | Dezzo Trading 392 (Pty) Ltd | active | Sept 2027 |
| RIGADEL 50 | 🇿🇦South Africa | Dezzo Trading 392 (Pty) Ltd | active | Sept 2027 |
| RIGADEL 200 | 🇿🇦South Africa | Dezzo Trading 392 (Pty) Ltd | active | Sept 2027 |
| LAMETEC | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | suspended | Jul 2025 |
| ADCO-MICTRIN 200 | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jun 2025 |
| ADCO-MICTRIN 100 | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jun 2025 |
| ADCO-MICTRIN 50 | 🇿🇦South Africa | Adcock Ingram Limited | suspended | Jun 2025 |
| LAMICTIN P2 | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | suspended | May 2025 |
| LAMICTIN P50 | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | suspended | May 2025 |
| TOCLON 25 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Dec 2023 |
| TOCLON 200 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Dec 2023 |
| TOCLON 50 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Dec 2023 |
| TOCLON 100 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | suspended | Dec 2023 |
| ORILAM_ODT_100 100MG ORALLY DISINTERGRATING TABLET ORALLY DISINTERGRATING TABLET | 🇲🇼Malawi | — | expired | Mar 2023 |
| ORILAM_ODT_50 50MG ORALLY DISINTERGRATING TABLET ORALLY DISINTERGRATING TABLET | 🇲🇼Malawi | — | expired | Mar 2023 |
| ORILAM_ODT_25 25MG ORALLY DISINTERGRATING TABLET ORALLY DISINTERGRATING TABLET | 🇲🇼Malawi | — | expired | Mar 2023 |
| LAMIDUS 100 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | suspended | Aug 2022 |
| LAMIDUS 50 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | suspended | Aug 2022 |
| LAMIDUS 200 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | suspended | Aug 2022 |
| ZYDUS-LAMOTRIGINE 100 mg TABLETS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | suspended | Aug 2022 |
| ZYDUS-LAMOTRIGINE 200 mg TABLETS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | suspended | Aug 2022 |
| ZYDUS LAMOTRIGINE 50 mg TABLETS | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | suspended | Aug 2022 |
| LAMOCAN 25 TABLET TABLET/3X10 | 🇳🇬Nigeria | CHANRAI HEALTH CARE LTD. 122-132 | expired | Jan 2021 |
| LAMILEP Comprime dispersible / 25 mg | 🇹🇳Tunisia | PHARMACARE | expired | Aug 2018 |
| LAMILEP Comprimé dispersible sécable / 100 mg | 🇹🇳Tunisia | PHARMACARE | expired | Aug 2018 |
| LAMILEP Comprimé dispersible sécable / 200 mg | 🇹🇳Tunisia | PHARMACARE | expired | Aug 2018 |
| LAMILEP Comprimé dispersible sécable / 50 mg | 🇹🇳Tunisia | PHARMACARE | expired | Aug 2018 |
| LAMICTAL Comprime dispersible / 50 mg | 🇹🇳Tunisia | GlaxoSmithKline France | expired | May 2008 |
| LAMICTAL Comprime dispersible / 200mg | 🇹🇳Tunisia | GlaxoSmithKline France | expired | Aug 2006 |
| LAMICTAL Comprime dispersible / 5 mg | 🇹🇳Tunisia | GlaxoSmithKline France | expired | Aug 2006 |
| LAMICTAL Comprime dispersible / 100 mg | 🇹🇳Tunisia | GlaxoSmithKline France | expired | Aug 2006 |
| LAMICTAL Comprime dispersible / 25 mg | 🇹🇳Tunisia | GlaxoSmithKline France | expired | Aug 2006 |
| LAMILEPSY 200 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | Jan 1900 |
| LAMICTIN 50 | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
| LAMICTIN 100 | 🇿🇦South Africa | GlaxoSmithKline South Africa (Pty) Limited | active | Jan 1900 |
Showing 50 of 164 registrations. Sign up free to search and export all.
LAMOTRIGINE in Africa — Regulatory Overview
LAMOTRIGINE is registered across 12 African markets with 164 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Morocco, Uganda, Zimbabwe and 8 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 164 registrations, 135 (82%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.